Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Kazdal

Showing results (11-20 of 114) with videos related to

Pageof 12
Sort By:
Pathology|July 1, 2018
Molecular dissection of large cell carcinomas of the lung with null immunophenotypeAlexander Harms, Volker Endris, Hauke Winter, et al.
Communications Biology|July 29, 2025
CG>TG mutation frequency as negative predictor of homologous recombination deficiency in ovarian and breast cancerEva Romanovsky, Michael Menzel, Klaus Kluck, et al.
Pathology|February 26, 2019
Agreement of CK5/6, p40, and p63 immunoreactivity in non-small cell lung cancerKatharina Kriegsmann, Martin Cremer, Christiane Zgorzelski, et al.
Pathologie (Heidelberg, Germany)|June 2, 2026
[Artificial intelligence in molecular pathology : Introduction and overview]Daniel Kazdal, Jan Budczies, Michael Menzel, et al.
Studies in Health Technology and Informatics|September 3, 2025
Whole Exome Sequencing on FHIR: Towards Adoption in Clinical Practice for Precision Oncology PipelinesSara Nuhic, Patrick Werner, Daniel Kazdal, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|August 5, 2017
Qualitative Comparison Between Carrier-based and Classical Tissue MicroarraysKatharina Lisenko, Jonas Leichsenring, Christiane Zgorzelski, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|October 26, 2018
Insulinoma-associated Protein 1 (INSM1) in Thoracic Tumors is Less Sensitive but More Specific Compared With Synaptophysin, Chromogranin A, and CD56Katharina Kriegsmann, Christiane Zgorzelski, Daniel Kazdal, et al.
Histopathology|December 16, 2017
Role of conventional immunomarkers, HNF4-α and SATB2, in the differential diagnosis of pulmonary and colorectal adenocarcinomasMark Kriegsmann, Alexander Harms, Rémi Longuespée, et al.
International Journal of Cancer|July 13, 2017
Spatial distribution of EGFR and KRAS mutation frequencies correlates with histological growth patterns of lung adenocarcinomasSteffen Dietz, Alexander Harms, Volker Endris, et al.
Oncogene|December 15, 2021
p53 partial loss-of-function mutations sensitize to chemotherapyBoris Klimovich, Nastasja Merle, Michelle Neumann, et al.
Pageof 12

Showing results (11-20 of 114) with videos related to

Sort By:
Pageof 12
Pathology|July 1, 2018
Molecular dissection of large cell carcinomas of the lung with null immunophenotypeAlexander Harms, Volker Endris, Hauke Winter, et al.
Communications Biology|July 29, 2025
CG>TG mutation frequency as negative predictor of homologous recombination deficiency in ovarian and breast cancerEva Romanovsky, Michael Menzel, Klaus Kluck, et al.
Pathology|February 26, 2019
Agreement of CK5/6, p40, and p63 immunoreactivity in non-small cell lung cancerKatharina Kriegsmann, Martin Cremer, Christiane Zgorzelski, et al.
Pathologie (Heidelberg, Germany)|June 2, 2026
[Artificial intelligence in molecular pathology : Introduction and overview]Daniel Kazdal, Jan Budczies, Michael Menzel, et al.
Studies in Health Technology and Informatics|September 3, 2025
Whole Exome Sequencing on FHIR: Towards Adoption in Clinical Practice for Precision Oncology PipelinesSara Nuhic, Patrick Werner, Daniel Kazdal, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|August 5, 2017
Qualitative Comparison Between Carrier-based and Classical Tissue MicroarraysKatharina Lisenko, Jonas Leichsenring, Christiane Zgorzelski, et al.
Applied Immunohistochemistry & Molecular Morphology : AIMM|October 26, 2018
Insulinoma-associated Protein 1 (INSM1) in Thoracic Tumors is Less Sensitive but More Specific Compared With Synaptophysin, Chromogranin A, and CD56Katharina Kriegsmann, Christiane Zgorzelski, Daniel Kazdal, et al.
Histopathology|December 16, 2017
Role of conventional immunomarkers, HNF4-α and SATB2, in the differential diagnosis of pulmonary and colorectal adenocarcinomasMark Kriegsmann, Alexander Harms, Rémi Longuespée, et al.
International Journal of Cancer|July 13, 2017
Spatial distribution of EGFR and KRAS mutation frequencies correlates with histological growth patterns of lung adenocarcinomasSteffen Dietz, Alexander Harms, Volker Endris, et al.
Oncogene|December 15, 2021
p53 partial loss-of-function mutations sensitize to chemotherapyBoris Klimovich, Nastasja Merle, Michelle Neumann, et al.
Pageof 12